Etiologic correlations between idiopathic polyneuritis and multiple sclerosis: therapeutic implications.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D046508:Culture Techniques; D003711:Demyelinating Diseases / Q000150:complications; D004679:Encephalomyelitis / Q000150:complications / Q000209:etiology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006967:Hypersensitivity / Q000150:complications; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D009175:Mycoplasma Infections / Q000150:complications; D009431:Neural Conduction; D011115:Polyneuropathies / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D011819:Rabies Vaccines / Q000009:adverse effects; D014777:Virus Diseases / Q000150:complications
D005938:Glucocorticoids; D011819:Rabies Vaccines; D000324:Adrenocorticotropic Hormone